AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care
30 August 2023 - 9:30PM
Business Wire
New name of company reflects unified global
presence and collective goal of creating healthier futures by
accelerating positive outcomes for customers and their patients
Company announces more than $5 million
commitment to global corporate philanthropic efforts
Cencora, Inc. (NYSE: COR) today announced the completion of its
name and stock ticker change from AmerisourceBergen Corporation
(NYSE: ABC), marking the latest stage of the company’s evolution as
a leader in global pharmaceutical services. Cencora will begin
trading under the new ticker symbol “COR” on the New York Stock
Exchange at the open of the market trading today, August 30,
2023.
Under the new name Cencora, the company unifies its 46,000
employees – across several global business segments – under one
identity, propelled by a bold vision and purpose-driven approach to
creating healthier futures.
The new name underscores Cencora’s experience and vision when it
comes to connecting manufacturers, providers, pharmacies and
patients, and ensuring the consistent, reliable flow of treatments
to those who need them at a time of growing complexity.
"Today is a significant and exciting milestone for Cencora. Our
new name is a reminder of our customers, their patients, and our
team members who are at the center of everything we do,” said
Steven H. Collis, Chairman, President & Chief Executive Officer
of Cencora. “It represents the healthier futures we strive for
serving as a trusted industry partner that prioritizes innovation,
advocates for patient access, and advances strategic partnerships
across the global pharmaceutical value chain.”
As a global healthcare company, Cencora will continue to invest
in and focus on its core pharmaceutical distribution business,
while also growing its platform of pharma and biopharma services to
support pharmaceutical innovation and access across the globe.
Aligned with the company’s purpose, and to commemorate this
seminal moment in the organization’s history, Cencora also
announced a $5 million donation to the Cencora Impact Foundation,
formerly known as the AmerisourceBergen Foundation, an independent
not-for-profit charitable giving organization. The donation will be
used to launch the Cencora Healthier Futures Grant Program, which
aims to identify opportunities to support those on the front lines
of healthcare in underserved populations who are driving innovation
in global health. Targeted donations from the Cencora Healthier
Futures Grant Program, operated by Cencora Impact Foundation, will
go toward nonprofits and charities around the world that are
advancing access to care and directly impacting communities in
need.
The inaugural donation out of the Cencora Healthier Futures
Grant Program will be a $500,000 grant made to the UNICEF Health
Fund, which focuses on ensuring that every child has the ability to
survive and thrive by providing strong primary healthcare systems,
training healthcare professionals, and working closely with
national governments to ensure programs are replicable at scale.
These system-wide responses aim to reduce the number of maternal
and newborn deaths, provide children with immunizations, reduce
malnutrition, address adolescent mental health, and combat the rise
of non-communicable diseases.
“We are grateful for support from the Cencora Impact Foundation
to help UNICEF deliver large-scale, sustainable results in ensuring
the health of the world’s most vulnerable children,” said V. Renée
Cutting, Chief Philanthropy Officer, UNICEF USA.
Cencora Ventures, formerly known as AB Health Ventures, the
company’s dedicated corporate venture fund, has also committed to
donating 10% of future realized profits to support the efforts of
the Cencora Impact Foundation and its continued work to improve
healthcare access globally.
For more information about the rebrand and updated design and
branding elements, visit: www.cencora.com
About Cencora
Cencora is a leading global pharmaceutical solutions
organization centered on improving the lives of people and animals
around the world. We partner with pharmaceutical innovators across
the value chain to facilitate and optimize market access to
therapies. Care providers depend on us for the secure, reliable
delivery of pharmaceuticals, healthcare products, and solutions.
Our 46,000+ worldwide team members contribute to positive health
outcomes through the power of our purpose: We are united in our
responsibility to create healthier futures. Cencora is ranked #11
on the Fortune 500 and #24 on the Global Fortune 500 with more than
$200 billion in annual revenue. Learn more at www.cencora.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230830469400/en/
Media: Lauren Esposito 215-460-6981
lesposito@amerisourcebergen.com Investors: Bennett S. Murphy
610-727-3693 bmurphy@amerisourcebergen.com
Camino Minerals (TSXV:COR)
Historical Stock Chart
From Nov 2024 to Dec 2024
Camino Minerals (TSXV:COR)
Historical Stock Chart
From Dec 2023 to Dec 2024